CVM
CEL SCI CORPCompany Information
- Company Name
- CEL SCI CORP
- CIK
- CIK0000725363
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CVM: NYSE
- Fiscal Year End
- September 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- CVM
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-25
- Last sale
- —
- Shares purchased (TTM)
- 546,412
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 1,933,403
- Shares outstanding
- 17,588,653
- Ownership
- 10.99%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 5.84%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 7 | 2 | 6 | 11 | 2 | 2 | 5 | 5 | 0 | 5 | 3 | 4 | ||||||
| Prepaid Expense Current | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Deposits Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | - | - | - | - | - | - | - | 1 | - | - | 2 | 2 | ||||||
| Assets Current | 8 | 3 | 7 | 12 | 3 | 3 | 6 | 6 | 4 | 9 | 6 | 7 | ||||||
| Finance Lease Right Of Use Asset | 4 | 5 | 5 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | ||||||
| Property Plant And Equipment Net | 5 | 5 | 6 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 10 | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deposits Assets | - | - | - | - | - | - | - | - | - | 2 | 2 | - | ||||||
| Deposits Assets Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | - | - | 2 | ||||||
| Assets | 21 | 18 | 23 | 28 | 20 | 22 | 26 | 27 | 24 | 30 | 29 | 31 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Inventory Noncurrent | - | - | - | - | - | - | - | 1 | - | - | - | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finance Lease Liability Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 5 | 6 | 5 | 5 | 6 | ||||||
| Finance Lease Liability Noncurrent | 4 | 4 | 5 | 6 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 10 | 11 | 12 | 12 | 13 | 14 | 14 | 14 | 16 | 16 | 16 | 17 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | ||||||
| Additional Paid In Capital | 567 | 557 | 556 | 555 | 540 | 535 | 532 | 527 | 516 | 515 | 506 | 500 | ||||||
| Retained Earnings Accumulated Deficit | -556 | -550 | -545 | -539 | -533 | -528 | -521 | -514 | -508 | -501 | -494 | -487 | ||||||
| Stockholders Equity | 11 | 7 | 11 | 16 | 7 | 8 | 11 | 13 | 8 | 14 | 13 | 13 | ||||||
| Liabilities And Stockholders Equity | 21 | 18 | 23 | 28 | 20 | 22 | 26 | 27 | 24 | 30 | 29 | 31 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | 600 | ||||||
| Common Stock Shares Issued | 18 | 8 | 8 | 8 | 5 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Shares Outstanding | 18 | 8 | 8 | 8 | 5 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCEL SCI CORP (CVM) — SEC Financial Statements & Analysis
CEL SCI CORP (CVM) is a biological products, (no diagnostic substances) company, incorporated in CO. CEL SCI CORP trades on NYSE as: CVM. CEL SCI CORP (CVM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, CEL SCI CORP carries a market cap of $18.29M, a P/E ratio of 0.65x, a P/B ratio of 1.67x, an enterprise value of $18.04M, and an EV/EBITDA multiple of -0.98x. On profitability, it posts a Return on Equity (ROE) of 312.76%, a Return on Assets (ROA) of 134.89%, and a Return on Invested Capital (ROIC) of -182.59%. Per share, it reports EPS of $1.60, diluted EPS of $2.32, free cash flow per share of $-0.95, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -1.06% year-over-year and EPS growth of -70.07% year-over-year. On the balance sheet, it maintains a current ratio of 1.48x, a quick ratio of 1.34x, working capital of $2.42M, a debt-to-equity ratio of 0.95x, a debt ratio of 0.49, an interest coverage ratio of -50.19x, free cash flow of $-16.75M (TTM), and net debt of $-255.57K. Figures sourced from SEC EDGAR.
- Market Cap
- $18.29M
- P/E TTM
- 0.65x
- EPS TTM
- $1.60
- P/B TTM
- 1.67x
- ROE TTM
- 312.76%
- ROA TTM
- 134.89%
- Debt To Equity
- 0.95x
- Free Cash Flow TTM
- $-16.75M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CEL SCI CORP in?
CEL SCI CORP (CVM) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does CVM trade on?
CEL SCI CORP (CVM) trades on the NYSE.
Where is CEL SCI CORP incorporated?
CEL SCI CORP is incorporated in CO.
When was CEL SCI CORP (CVM)'s most recent SEC filing?
CEL SCI CORP (CVM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is CVM's market cap?
CEL SCI CORP (CVM) has a market capitalization of $18.29M as of 2026-06-30.
What is CVM's P/E ratio?
CEL SCI CORP (CVM)'s trailing twelve month P/E ratio is 0.65x as of 2026-06-30.
What is CVM's EPS (earnings per share)?
CEL SCI CORP (CVM)'s trailing twelve month EPS is $1.60 as of 2026-06-30.
What is CVM's ROE (return on equity)?
CEL SCI CORP (CVM)'s trailing twelve month Return on Equity (ROE) is 312.76% as of 2026-06-30.
What is CVM's ROA (return on assets)?
CEL SCI CORP (CVM)'s trailing twelve month Return on Assets (ROA) is 134.89% as of 2026-06-30.
What is CVM's ROIC (return on invested capital)?
CEL SCI CORP (CVM)'s trailing twelve month Return on Invested Capital (ROIC) is -182.59% as of 2026-06-30.
What is CVM's EV/EBITDA?
CEL SCI CORP (CVM)'s trailing twelve month EV/EBITDA is -0.98x as of 2026-06-30.